FHLC vs. BBH: Which Healthcare ETF Is the Better Buy?
Compare fees, diversification, and risk between these two leading healthcare ETFs.
Overview
Choosing between a broad healthcare fund and a focused biotech fund comes down to how much risk -- and potential reward -- an investor is willing to take on. The Fidelity MSCI Health Care Index ETF (NYSEMKT:FHLC) and the VanEck Biotech ETF (NASDAQ:BBH) both offer exposure to the healthcare sector, but they go about it in very different ways.
FHLC tracks a broad index of pharmaceutical, medical device, and healthcare service companies, whereas BBH focuses specifically on the 25 largest US-listed biotechnology firms.
Details
Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-year return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
Source
Originally published at www.fool.com.